These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9103733)

  • 21. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
    Denys D
    Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
    Vloet TD; Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
    Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E
    Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J; Judge R
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone.
    Biondi M; Picardi A
    Psychother Psychosom; 2005; 74(2):123-8. PubMed ID: 15741763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.
    Noorbala AA; Hosseini SH; Mohammadi MR; Akhondzadeh S
    J Clin Pharm Ther; 1998 Apr; 23(2):155-9. PubMed ID: 9786103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
    Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
    Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C; Freeston MH; Borgeat F
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating obsessive compulsive disorder.
    Veale D
    Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
    [No Abstract]   [Full Text] [Related]  

  • 33. How to treat OCD in patients with Tourette syndrome.
    Miguel EC; Shavitt RG; Ferrão YA; Brotto SA; Diniz JB
    J Psychosom Res; 2003 Jul; 55(1):49-57. PubMed ID: 12842231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.
    Marazziti D; Carlini M; Dell'Osso L
    Curr Top Med Chem; 2012; 12(4):238-53. PubMed ID: 22204483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of OCD].
    Sumitani S; Ohmori T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):442-5. PubMed ID: 12877022
    [No Abstract]   [Full Text] [Related]  

  • 36. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
    Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
    Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in the treatment of obsessive-compulsive disorder.
    Leonard HL
    J Clin Psychiatry; 1997; 58 Suppl 14():39-45; discussion 46-7. PubMed ID: 9418745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
    Flament MF; Bisserbe JC
    J Clin Psychiatry; 1997; 58 Suppl 12():18-22. PubMed ID: 9393392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OCD: where the serotonin selectivity story begins.
    Pigott TA
    J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatry of obsessive-compulsive disorder in children and adolescents.
    March JS; Leonard HL; Swedo SE
    Compr Ther; 1995 Sep; 21(9):507-12. PubMed ID: 8565438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.